BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32804611)

  • 21. Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area.
    Vahidy FS; Drews AL; Masud FN; Schwartz RL; Askary BB; Boom ML; Phillips RA
    JAMA; 2020 Sep; 324(10):998-1000. PubMed ID: 32789492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 24. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China.
    Shi S; Qin M; Shen B; Cai Y; Liu T; Yang F; Gong W; Liu X; Liang J; Zhao Q; Huang H; Yang B; Huang C
    JAMA Cardiol; 2020 Jul; 5(7):802-810. PubMed ID: 32211816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.
    Fragoso-Saavedra S; Iruegas-Nunez DA; Quintero-Villegas A; García-González HB; Nuñez I; Carbajal-Morelos SL; Audelo-Cruz BM; Arias-Martínez S; Caro-Vega Y; Calva JJ; Luqueño-Martínez V; González-Duarte A; Crabtree-Ramírez B; Crispín JC; Sierra-Madero J; Belaunzarán-Zamudio PF; Valdés-Ferrer SI
    BMC Infect Dis; 2020 Oct; 20(1):765. PubMed ID: 33066761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology.
    Wunsch H
    Am J Respir Crit Care Med; 2020 Jul; 202(1):1-4. PubMed ID: 32402207
    [No Abstract]   [Full Text] [Related]  

  • 27. Decreased prealbumin level is associated with increased risk for mortality in elderly hospitalized patients with COVID-19.
    Zuo P; Tong S; Yan Q; Cheng L; Li Y; Song K; Chen Y; Dai Y; Gao H; Zhang C
    Nutrition; 2020 Oct; 78():110930. PubMed ID: 32854020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China.
    Xie J; Tong Z; Guan X; Du B; Qiu H
    JAMA Netw Open; 2020 Apr; 3(4):e205619. PubMed ID: 32275319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of non-invasive ventilation in COVID-19 critically ill patients: A Retrospective observational Study.
    Mukhtar A; Lotfy A; Hasanin A; El-Hefnawy I; El Adawy A
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):579-580. PubMed ID: 32736030
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
    Urra JM; Cabrera CM; Porras L; Ródenas I
    Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.
    Paranjpe I; Fuster V; Lala A; Russak AJ; Glicksberg BS; Levin MA; Charney AW; Narula J; Fayad ZA; Bagiella E; Zhao S; Nadkarni GN
    J Am Coll Cardiol; 2020 Jul; 76(1):122-124. PubMed ID: 32387623
    [No Abstract]   [Full Text] [Related]  

  • 32. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2.
    Elamari S; Motaib I; Zbiri S; Elaidaoui K; Chadli A; Elkettani C
    Pan Afr Med J; 2020; 37():32. PubMed ID: 33209159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-Term Dexamethasone in Sars-CoV-2 Patients.
    Selvaraj V; Dapaah-Afriyie K; Finn A; Flanigan TP
    R I Med J (2013); 2020 Jun; 103(6):39-43. PubMed ID: 32570995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients.
    Moreno-P O; Leon-Ramirez JM; Fuertes-Kenneally L; Perdiguero M; Andres M; Garcia-Navarro M; Ruiz-Torregrosa P; Boix V; Gil J; Merino E;
    Int J Infect Dis; 2020 Nov; 100():449-454. PubMed ID: 32950739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study.
    Hirashima T; Arai T; Kitajima H; Tamura Y; Yamada T; Hashimoto S; Morishita H; Minamoto S; Kawashima K; Kashiwa Y; Kameda M; Takeshita T; Suzuki H; Matsuoka H; Yamaguchi S; Tanaka T; Nagai T
    J Infect Chemother; 2021 Jan; 27(1):76-82. PubMed ID: 33051144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. We urgently need guidelines for managing COVID-19 in children with comorbidities.
    Dayal D
    Acta Paediatr; 2020 Jul; 109(7):1497-1498. PubMed ID: 32279351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The characterization of chronic rhinosinusitis in hospitalized patients with COVID-19.
    Wang H; Song J; Pan L; Yao Y; Deng YK; Wang ZC; Liao B; Ma J; He C; Zeng M; Liu Z
    J Allergy Clin Immunol Pract; 2020; 8(10):3597-3599.e2. PubMed ID: 32980581
    [No Abstract]   [Full Text] [Related]  

  • 38. Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda.
    Kirenga B; Muttamba W; Kayongo A; Nsereko C; Siddharthan T; Lusiba J; Mugenyi L; Byanyima RK; Worodria W; Nakwagala F; Nantanda R; Kimuli I; Katagira W; Bagaya BS; Nasinghe E; Aanyu-Tukamuhebwa H; Amuge B; Sekibira R; Buregyeya E; Kiwanuka N; Muwanga M; Kalungi S; Joloba ML; Kateete DP; Byarugaba B; Kamya MR; Mwebesa H; Bazeyo W
    BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32900781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Young Adults with COVID-19, Obesity Is Associated with Adverse Outcomes.
    Steinberg E; Wright E; Kushner B
    West J Emerg Med; 2020 Jun; 21(4):752-755. PubMed ID: 32726235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients.
    Klopfenstein T; Zayet S; Lohse A; Selles P; Zahra H; Kadiane-Oussou NJ; Toko L; Royer PY; Balblanc JC; Gendrin V; Conrozier T;
    Int J Infect Dis; 2020 Oct; 99():491-495. PubMed ID: 32798660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.